Stub Trine, Musial Frauke, Quandt Sara A, Arcury Thomas A, Salamonsen Anita, Kristoffersen Agnete, Berntsen Gro
Department of Community Medicine, The National Research Center in Complementary and Alternative Medicine (NAFKAM), UiT The Arctic University of Norway, Tromsø, Norway Department of Epidemiology and Prevention, Division of Public Health Sciences, Wake Forest School of Medicine, Winston-Salem, North Carolina, USA.
Department of Community Medicine, The National Research Center in Complementary and Alternative Medicine (NAFKAM), UiT The Arctic University of Norway, Tromsø, Norway.
BMJ Open. 2015 Sep 3;5(9):e008236. doi: 10.1136/bmjopen-2015-008236.
Studies show that patients with cancer who use complementary and alternative medicine (CAM) have a poorer survival prognosis than those who do not. It remains unclear whether this is due to a priori poorer prognosis that makes patients turn to CAM, or whether there is a factor associated with CAM use itself that influences the prognosis negatively. Healthcare providers should assist patients in safeguarding their treatment decision. However, the current non-communication between CAM and conventional providers leaves it up to the patients themselves to choose how to best integrate the two worlds of therapy. In this study, an interactive shared decision-making (SDM) tool will be developed to enable patients and health professionals to make safe health choices.
We will delineate, compare and evaluate perception and clinical experience of communication of risk situations among oncology experts, general practitioners and CAM practitioners. To accomplish this, we will develop a pilot and implement a large-scale survey among the aforementioned health professionals in Norway. Guided by the survey results, we will develop a β-version of a shared decision-making tool for healthcare providers to use in guiding patients to make safe CAM decisions.
Participants must give their informed and written consent before inclusion. They will be informed about the opportunity to drop out from the study followed by deletion of all data registered. The study needs no approval from The Regional Committee for Medical and Health Research Ethics because all participants are healthcare professionals. Results from this study will be disseminated in peer-reviewed medical journals.
研究表明,使用补充和替代医学(CAM)的癌症患者的生存预后比不使用的患者更差。目前尚不清楚这是由于预后较差导致患者转向补充和替代医学,还是存在与使用补充和替代医学本身相关的因素对预后产生负面影响。医疗保健提供者应协助患者保护其治疗决策。然而,目前补充和替代医学提供者与传统提供者之间缺乏沟通,这使得患者只能自行选择如何最好地整合这两种治疗方式。在本研究中,将开发一种交互式共享决策(SDM)工具,使患者和卫生专业人员能够做出安全的健康选择。
我们将描述、比较和评估肿瘤专家、全科医生和补充和替代医学从业者对风险情况沟通的认知和临床经验。为此,我们将开展一项试点研究,并在挪威上述卫生专业人员中进行大规模调查。以调查结果为指导,我们将开发一个β版的共享决策工具,供医疗保健提供者用于指导患者做出安全的补充和替代医学决策。
参与者在纳入研究前必须给予知情书面同意。他们将被告知有退出研究的机会,随后删除所有已注册的数据。由于所有参与者都是医疗保健专业人员,该研究无需获得地区医学和健康研究伦理委员会的批准。本研究的结果将在同行评审医学期刊上发表。